The United States Patent and Trademark Office (USPTO) has published the trademark application for 'PINAINICE' (TM99467865). This publication signifies that the mark has passed initial examination and is now open for a period of opposition by third parties. The application covers a range of pharmaceutical products, including medicated skin care preparations, mouthwash, bee venom for medicinal purposes, and substances for treating various conditions such as damaged skin, pain, inflammation, and cognitive disorders.

While this is a trademark publication and not a regulatory rule, companies in the pharmaceutical sector should be aware of new marks being registered, as they can indicate new product launches or market entries. The filing date was October 29, 2025, and the publication date is March 22, 2026. There are no immediate compliance actions required for other entities based on this publication, but it serves as an indicator of potential new market players or product lines.